FACULTY:
Philip Levy, MD is a neonatologist at Boston Children’s Hospital and an Associate Professor of Pediatrics at Harvard Medical School.
OVERVIEW:
When to Consider Procedural Closure of the Patent Ductus Arteriosus in Premature Infants
OVERALL LEARNING OBJECTIVE:
Increased awareness and education for pediatric providers
DISCLOSURE TO LEARNERS:
Philip Levy, MD, has disclosed he is a speaker for Abbot Congenital. The relevant financial relationships noted for Dr. Levy have been mitigated.
The Pediatric Grand Rounds Planning Committee (Deepak Kamat, MD, PhD, Steven Seidner, MD, Daniel Ranch, MD and Elizabeth Hanson, MD) has no financial relationships with ineligible companies to disclose.
The UT Health Science Center San Antonio and Deepak Kamat, MD course director and content reviewer for the activity, have reviewed all financial disclosure information for all speakers, facilitators, and planning committee members; and determined and resolved all conflicts of interests.
CONTINUING MEDICAL EDUCATION STATEMENTS:
The UT Health Science Center San Antonio is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The UT Health Science Center San Antonio designates this live activity up to a maximum of 1.00 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn 1 MOC point in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.
CERTIFICATE OF ATTENDANCE:
Healthcare professionals will receive a certificate of attendance and are asked to consult with their licensing board for information on applicability and acceptance.
Credit may be obtained upon successful completion of the activity’s evaluation.
RELEASE DATE:
3/21/2025
EXPIRATION DATE:
8/31/2027